MediciNova Research And Ddevelopement To Revenue from 2010 to 2025
MNOV Stock | USD 2.10 0.01 0.47% |
Research And Ddevelopement To Revenue | First Reported 2010-12-31 | Previous Quarter 6.51 | Current Value 6.18 | Quarterly Volatility 5.47489042 |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Research And Ddevelopement To Revenue |
Latest MediciNova's Research And Ddevelopement To Revenue Growth Pattern
Below is the plot of the Research And Ddevelopement To Revenue of MediciNova over the last few years. It is the ratio of a company's research and development expenses to its total revenue, indicating how much of the revenue is invested back into developing new products or services. MediciNova's Research And Ddevelopement To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
Research And Ddevelopement To Revenue | 10 Years Trend |
|
Research And Ddevelopement To Revenue |
Timeline |
MediciNova Research And Ddevelopement To Revenue Regression Statistics
Arithmetic Mean | 4.76 | |
Geometric Mean | 3.24 | |
Coefficient Of Variation | 115.02 | |
Mean Deviation | 3.38 | |
Median | 2.11 | |
Standard Deviation | 5.47 | |
Sample Variance | 29.97 | |
Range | 22.5221 | |
R-Value | (0.33) | |
Mean Square Error | 28.74 | |
R-Squared | 0.11 | |
Significance | 0.23 | |
Slope | (0.41) | |
//window.location = "/error404.html"; |